(R)-3-(3-Chlorophenyl)-3-((6-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy)pyridazin-3-yl)amino)propanoic Acid

ID: ALA4471108

PubChem CID: 155534872

Max Phase: Preclinical

Molecular Formula: C23H24ClN5O3

Molecular Weight: 453.93

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(O)C[C@@H](Nc1ccc(OCCc2ccc3c(n2)NCCC3)nn1)c1cccc(Cl)c1

Standard InChI:  InChI=1S/C23H24ClN5O3/c24-17-5-1-3-16(13-17)19(14-22(30)31)27-20-8-9-21(29-28-20)32-12-10-18-7-6-15-4-2-11-25-23(15)26-18/h1,3,5-9,13,19H,2,4,10-12,14H2,(H,25,26)(H,27,28)(H,30,31)/t19-/m1/s1

Standard InChI Key:  YSHCUQUSNSOANU-LJQANCHMSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   29.9132   -4.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6296   -4.3056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6268   -3.4751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9114   -3.0660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1985   -4.3060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1981   -3.4788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4853   -3.0677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.7684   -3.4795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7689   -4.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4861   -4.7223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3396   -3.0599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0556   -3.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7683   -3.0546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.4843   -3.4643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4843   -4.2881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1994   -4.6978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9132   -4.2826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9075   -3.4534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.1918   -3.0475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6297   -4.6914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3420   -4.2753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0585   -4.6841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7708   -4.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4873   -4.6769    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.7665   -3.4431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.3377   -3.4504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0517   -3.0365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0479   -2.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3308   -1.8028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6162   -2.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6236   -3.0461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7604   -1.7967    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  3 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 21 26  1  1
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 28 32  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4471108

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 453.93

Molecular Weight (Monoisotopic): 453.1568

AlogP: 4.13

#Rotatable Bonds: 9

Polar Surface Area: 109.26

Molecular Species: ACID

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 3.69

CX Basic pKa: 7.18

CX LogP: 1.59

CX LogD: 1.19

Aromatic Rings: 3

Heavy Atoms: 32

QED Weighted: 0.44

Np Likeness Score: -0.94

References

1. Anderson NA, Campos S, Butler S, Copley RCB, Duncan I, Harrison S, Le J, Maghames R, Pastor-Garcia A, Pritchard JM, Rowedder JE, Smith CE, Thomas J, Vitulli G, Macdonald SJF..  (2019)  Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis.,  62  (19): [PMID:31497959] [10.1021/acs.jmedchem.9b00962]

Source

Source(1):

• Scientific Literature